DRUGRECURE ApS: Financial statements 2022
CVR: 29154406
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
DRUGRECURE ApS (CVR 29154406) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -66,145,000 and a net result of DKK -84,355,000 compared with DKK -140,215,000 the year before. Equity in the 2022 report amounted to DKK -669,587,000.
- Gross Profit
- DKK -66,145,000
- Profit/Loss
- DKK -84,355,000
- Equity
- DKK -669,587,000
- Total Assets
- DKK 37,705,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -66.1M | -84.4M | -669.6M | - |
| 2021 | - | -88.6M | -140.2M | -292M | - |
| 2020 | - | -121.7M | -143M | -151.8M | - |
| 2019 | - | -33.8M | -60.1M | -8.8M | 0 |
| 2018 | - | -15.9M | -15.9M | 51.3M | - |
Official annual report
Keep an eye on DRUGRECURE ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
DRUGRECURE ApS has published its annual report for 2021. Gross profit came to DKK -88,638,000, and the net result was DKK -140,215,000.
About DRUGRECURE ApS
DRUGRECURE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named ApS KBUS 17 NR. 4495. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -231,083,000 and a net result of DKK -282,428,000 compared with DKK -274,629,000 the year before. Equity in the 2025 report amounted to DKK -1,360,145,000.